Delivery Order SPE2DB22D3401-SPE2DB25FT6FM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,031.58 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count) on August 21, 2025, with completion expected by August 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,218.96 to AmerisourceBergen Drug Corp for the supply of Promethegan 12.5 mg suppositories (12-count packages). This firm fixed-price delivery order, issued on July 26, 2025, with completion targeted for July 28, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award was made through open competition with no set-aside designation, and performance will be executed at the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,004.03 firm fixed-price delivery order is for the supply of PROMETHEGAN 25 MG SUPPOSITORY 12S medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,679.75, is for the delivery of PROMETHEGAN 25 MG SUPPOSITORY 12S, a pharmaceutical product. The contract has a completion date of December 4, 2023, and is a firm fixed-price type with no set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,794.40 firm fixed price delivery order to provide PROMETHEGAN 25 MG SUPPOSITORY 12S pharmaceutical products. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMETHEGAN 12.5 MG SUPPOS 12S medication. The contract has a ceiling value of $6,126.98 and a completion date of June 27, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,256.80 firm-fixed-price delivery order is for the supply of PROMETHEGAN 12.5 MG SUPPOS 12S, a pharmaceutical product. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $2,356.50, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PROMETHEGAN 25 MG SUPPOSITORY 12S, a pharmaceutical product, with a completion date of March 13, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $314,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 25 mg suppository medications. As the prime contractor, Amerisourcebergen will deliver 12 units of Promethgan suppositories to a facility in Conshohocken, Pennsylvania by July 12, 2023 in support of DLA's medical logistics programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceutical...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order valued at $1,519.37 to provide PROMETHAZINE 12.5 MG SUPPOS 12S, a pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6FMDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Promethegan 12.5 mg suppositories (quantity: 12 units) with a ceiling value of $1,950.24. This firm fixed-price delivery order, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation and was competitively awarded. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 pharmaceutical prime vendor agreement running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare systems worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive capability in delivering pharmaceuticals across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet diverse federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/16/25 |